Characterisation and clinical usefulness of CA130 antigen recognised by monoclonal antibodies, 130-22 and 145-9, in ovarian cancers.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/7BCCBF70.svg?ark=w1%2F20260515%2F7BCCBF70)](https://nobleid.org/work/w1/20260515/7BCCBF70)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors